Perspective Therapeutics, Inc. financial data

Symbol
CATX on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
2401 Elliott Avenue, Suite 320, Seattle, Washington
State of incorporation
Delaware
Fiscal year end
December 31
Former names
IsoRay, Inc. (to 2/16/2023), Isoray, Inc. (to 2/16/2023), CENTURY PARK PICTURES CORP (to 8/3/2005)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 552 % -56.5%
Quick Ratio 18.2 % -64.6%
Debt-to-equity 18.4 % +155%
Return On Equity -45.6 % -240%
Return On Assets -38.5 % -208%
Operating Margin -93.7 % -91.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 587M shares +110%
Common Stock, Shares, Outstanding 587M shares +111%
Entity Public Float 186M USD +328%
Common Stock, Value, Issued 587K USD +110%
Weighted Average Number of Shares Outstanding, Basic 495M shares +117%
Weighted Average Number of Shares Outstanding, Diluted 495M shares +117%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.19M USD +27.3%
Research and Development Expense 25.5M USD +599%
Selling and Marketing Expense 855K USD +6.88%
General and Administrative Expense 20.3M USD +61.4%
Operating Income (Loss) -44.2M USD -159%
Nonoperating Income (Expense) 1.66M USD +75.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -42.5M USD -164%
Income Tax Expense (Benefit) -2.65M USD
Net Income (Loss) Attributable to Parent -58.4M USD -497%
Earnings Per Share, Basic -0.19 USD/shares -171%
Earnings Per Share, Diluted -0.02 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 142M USD +290%
Cash, Cash Equivalents, and Short-term Investments 181M USD
Accounts Receivable, after Allowance for Credit Loss, Current 999K USD
Inventory, Net 1.01M USD -34.8%
Other Assets, Current 45K USD
Assets, Current 188M USD +367%
Property, Plant and Equipment, Net 14.3M USD +112%
Operating Lease, Right-of-Use Asset 1.06M USD +242%
Intangible Assets, Net (Excluding Goodwill) 354K USD +1316%
Goodwill 24.1M USD -11.9%
Other Assets, Noncurrent 482K USD -15%
Assets 278M USD +118%
Liabilities, Current 14.5M USD +102%
Deferred Income Tax Liabilities, Net 4.59M USD
Operating Lease, Liability, Noncurrent 1.04M USD +2257%
Liabilities 48.4M USD +403%
Retained Earnings (Accumulated Deficit) -165M USD -55%
Stockholders' Equity Attributable to Parent 230M USD +94.8%
Liabilities and Equity 278M USD +118%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 13.8M USD
Net Cash Provided by (Used in) Financing Activities 166M USD
Net Cash Provided by (Used in) Investing Activities -47.3M USD -287%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 587M shares +111%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 133M USD +760%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 59.1M USD -9.13%
Interest Paid, Excluding Capitalized Interest, Operating Activities 84K USD
Deferred Tax Assets, Valuation Allowance 30M USD +45.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 38.8M USD +88.6%
Operating Lease, Liability 1.17M USD +260%
Depreciation 346K USD +92.2%
Payments to Acquire Property, Plant, and Equipment 9.07M USD +4413%
Lessee, Operating Lease, Liability, to be Paid 1.4M USD +316%
Property, Plant and Equipment, Gross 15.3M USD +5.32%
Operating Lease, Liability, Current 128K USD -54.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 324K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 329K USD +179%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 238K USD +1731%
Lessee, Operating Lease, Liability, to be Paid, Year Three 320K USD
Deferred Tax Assets, Operating Loss Carryforwards 26.8M USD +39.8%
Deferred Federal Income Tax Expense (Benefit) -2.65M USD
Current Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 7M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 283K USD
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 7K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 11K USD
Share-based Payment Arrangement, Expense 2.78M USD -36.7%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 60K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%